Lyndon Kim, MD

Clinical Focus

• Acoustic Neuroma
• Brain / Nervous System Cancer
• Brain / Spinal Cord Cancer
• Brain Metastasis
• Brain Tumors
• Brain, Spine Tumors
• Cancer Treatment
• Chondrosarcoma
• Chordoma

Show More

• Acoustic Neuroma
• Brain / Nervous System Cancer
• Brain / Spinal Cord Cancer
• Brain Metastasis
• Brain Tumors
• Brain, Spine Tumors
• Cancer Treatment
• Chondrosarcoma
• Chordoma
• Glioblastoma Multiforme
• Hemangioblastoma
• Infusion Therapy
• Lumbar Puncture
• Meningioma
• Neuro-Oncology
• Neurofibromatosis
• Paraneoplastic Syndromes, Central Nervous System
• Pituitary Adenoma
• Pituitary Tumor
• Primary Central Nervous System Lymphoma
• Skull Base Tumor/Cancer
• Spinal Cord Tumors

Locations

Ruttenberg Treatment Center

1470 Madison Avenue, 3rd Floor, New York, NY, 10029

212-824-8579

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:19

Article:34

Review Article:4

Comment/Debate:3

Chapter:1

Recent Artifacts

• Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination with Extension of Survival among Patients with Newly Diagnosed and Recurrent Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial
• Proteogenomic and metabolomic characterization of human glioblastoma
• Phase Ib clinical trial of IGV-001 for patients with newly diagnosed glioblastoma
• A narrative review of targeted therapies in meningioma
• Effect of Vocimagene Amiretrorepvec in Combination with Flucytosine vs Standard of Care on Survival following Tumor Resection in Patients with Recurrent High-Grade Glioma: A Randomized Clinical Trial
• NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma
• Outcomes after stereotactic radiosurgery for CNS lymphoma
• A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma
• Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients
• Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Kim did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.